Can primary packaging selection help mitigate particulate risks in cell and gene therapy manufacturing?

Primary containers are critical components of cell and gene therapy manufacturing that are a known source of particulates. This article will discuss primary container criteria that may help mitigate the risk of visible particulates within cell processing and evaluate closed-system containers as alternatives to standard cryobags.

Please enter your email to access content Read now